Vitamin D and kidney disease

Area of Science:

• Nephrology
• Endocrinology
• Nutritional Science

Background:

• Secondary hyperparathyroidism in chronic kidney disease (CKD) is linked to impaired vitamin D metabolism.
• CKD patients often exhibit vitamin D insufficiency/deficiency, impacting 1,25-dihydroxyvitamin D levels.
• This necessitates therapeutic interventions to correct vitamin D status.

Purpose of the Study:

• To investigate the role of vitamin D metabolism abnormalities in CKD pathogenesis.
• To evaluate the efficacy of vitamin D repletion strategies in CKD.
• To explore potential non-classical actions and benefits of vitamin D in CKD.

Main Methods:

• Review of existing literature on vitamin D metabolism in CKD.
• Analysis of mechanisms leading to decreased 1,25-dihydroxyvitamin D in CKD.
• Examination of observational and experimental data on vitamin D sterol administration.

Main Results:

• Progressive decline of 1,25-dihydroxyvitamin D in CKD is multifactorial.
• Nutritional vitamin D deficiency is common in CKD, exacerbating vitamin D metabolism issues.
• Variable efficacy of native vitamin D therapy necessitates considering active vitamin D sterols.

Conclusions:

• Abnormal vitamin D metabolism is central to CKD complications like secondary hyperparathyroidism.
• Vitamin D therapy in CKD requires careful consideration of native vs. active forms.
• Further research, including randomized controlled trials, is needed to confirm survival and kidney disease progression benefits of vitamin D sterols.